Clinical Trials Logo

Filter by:
NCT ID: NCT04065477 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Improving Time-Based Prospective Memory in TBI

TBPM
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

This research aims to test aspects of a computer-based cognitive rehabilitation program designed to improve thinking skills in individuals with traumatic brain injury (TBI).

NCT ID: NCT04065347 Active, not recruiting - HIV/AIDS Clinical Trials

Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

Start date: November 21, 2019
Phase:
Study type: Observational

This study is being done to evaluate the relationship between adherence to antiretroviral therapy (ART) and HIV drug concentrations in persons living with HIV (PLWH) that are taking tenofovir alafenamide (TAF). Adherence will be measured with an ingestible biosensor (digital pill). Antiretroviral drug concentrations will be measured in different types of blood cells.

NCT ID: NCT04064762 Active, not recruiting - Clinical trials for Post Traumatic Stress Disorder

Targeted Plasticity Therapy for Posttraumatic Stress Disorder

Start date: December 16, 2020
Phase: N/A
Study type: Interventional

Posttraumatic stress disorder is a debilitating condition that develops in the aftermath of a traumatic experience, leading to hyperarousal, heightened anxiety, and uncontrolled fear that can be driven by intrusive memories or trauma reminders. The Texas Biomedical Device Center has developed a novel technique, termed targeted plasticity therapy (TPT), to boost neuroplasticity in conjunction with various forms of rehabilitation, including prolonged exposure therapy. The technique involves stimulation of the vagus nerve. The purpose of this open-label pilot study is to assess the safety of using a new device to deliver vagus nerve stimulation to reduce symptom severity in participants with PTSD when paired with prolonged exposure therapy. Additionally, the study will assess the prospective benefit of the system and garner an initial estimate of efficacy for a subsequent trial.

NCT ID: NCT04064567 Active, not recruiting - HIV/AIDS Clinical Trials

Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK

Start date: September 30, 2019
Phase: N/A
Study type: Interventional

Our proposed study will: provide a novel exploration of facilitators and barriers to PrEP; allow us to target hard to reach populations, including men who have sex with men (MSM) and substance users (both of which are top funding priority groups for the National Institutes of Health) who experience intersecting markers of HIV risk; and inform regional, and possibly national, intervention approaches to combat the overlapping epidemic of HIV and incarceration.

NCT ID: NCT04063878 Active, not recruiting - Clinical trials for Jaw, Edentulous, Partially

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration

Start date: July 30, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the outcome of prosthetic survival of the Acuris conometric concept 1 year after permanent restoration, since this is a new mode of retention using friction for seating the crown of single tooth restorations without using cement or screws.

NCT ID: NCT04063215 Active, not recruiting - Clinical trials for Traumatic Brain Injury

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Start date: January 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This study aims to determine the safety of HB-adMSC infusion and treatment effects of HB-adMSC infusion on brain structure, neurocognitive/functional outcomes, and neuroinflammation after subacute and chronic neurological injury in adults.

NCT ID: NCT04062708 Active, not recruiting - Clinical trials for Stage IIIB Non-small Cell Lung Cancer

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Start date: March 10, 2021
Phase: Phase 2
Study type: Interventional

This is a single arm, phase II trial of combined neoadjuvant platinum doublet chemotherapy plus durvalumab followed by surgery, postoperative radiation and adjuvant durvalumab for 13 cycles for patients with potentially resectable stage IIIA and IIIB (T1-3, N2) NSCLC (per the 8th International Association for the Study of Lung Cancer classification). The primary objective of this study is to increase N2 nodal clearance (N2NC) to 50% or greater for combined platinum doublet chemotherapy with durvalumab induction therapy from historical rate of 30% for platinum doublet chemotherapy alone in patients with potentially resectable stage IIIA/B (N2) NSCLC.

NCT ID: NCT04062630 Active, not recruiting - Clinical trials for Sacroiliac Joint Disruption

SI Joint Stabilization in Long Fusion to the Pelvis

SILVIA
Start date: May 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to compare outcomes of subjects undergoing multilevel lumbar fusion (MLF) surgery with and without the iFuse 3-D implants in the "bedrock" trajectory.

NCT ID: NCT04062526 Active, not recruiting - Parkinson Disease Clinical Trials

Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

Start date: August 14, 2019
Phase: Early Phase 1
Study type: Interventional

The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an imaging drug called 18F-NOS which will be used to measure inflammation in the brain.

NCT ID: NCT04062214 Active, not recruiting - Pain Clinical Trials

Pragmatic RCT of SBIRT-PM

Start date: October 23, 2019
Phase: N/A
Study type: Interventional

Veterans seeking compensation for musculoskeletal (MSD) conditions often develop chronic pain and are at high risk for substance misuse. The Investigators propose to test the effectiveness and cost-effectiveness of Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM), designed to reduce pain and reduce risky substance use, in part by helping Veterans get comprehensive pain treatment. The study will involve clinicians at a single site contacting Veterans throughout New England by phone to deliver SBIRT-PM counseling in a pragmatic, randomized, clinical trial.